- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Top Stock Picks from Analysts
U.S. Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
539
0 new
Companies which are more than 50% undervalued based on analyst price target.
539 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
BIIB | US$150.18 | -2.0% | -39.5% | US$21.7b | US$230.88 | PE13.5x | E10.3% | n/a | ||
ONC | US$184.61 | 2.2% | 5.4% | US$18.8b | US$280.92 | PS6.1x | E58.7% | n/a | ||
MRNA | US$35.15 | -17.4% | -66.8% | US$16.3b | US$73.19 | PS2.7x | E27.1% | n/a | ||
SMMT | US$18.18 | 4.0% | 486.3% | US$13.2b | US$32.55 | PB30.6x | E38.9% | n/a | ||
SRPT | US$118.43 | -7.4% | 1.4% | US$11.9b | US$184.91 | PE92.8x | E31.9% | n/a | ||
PCVX | US$81.17 | -5.6% | 33.7% | US$10.1b | US$149.89 | PB3x | E17.3% | n/a | ||
ROIV | US$10.74 | -6.7% | -2.9% | US$7.7b | US$16.14 | PE1.7x | E-60.6% | n/a | ||
RVMD | US$42.57 | -2.9% | 49.4% | US$7.7b | US$73.43 | PS10602.1x | E19.8% | n/a | ||
LEGN | US$32.50 | -6.4% | -46.5% | US$6.2b | US$81.75 | PS11.5x | E56.6% | n/a | ||
TEM | US$32.34 | -20.7% | n/a | US$5.9b | US$58.44 | PS8x | E37.0% | n/a | ||
CYTK | US$46.71 | -5.0% | -45.4% | US$5.5b | US$81.71 | PS1712.5x | E44.7% | n/a | ||
IONS | US$34.94 | 2.5% | -34.7% | US$5.3b | US$61.32 | PS6.9x | E42.0% | n/a | ||
NUVL | US$71.86 | -10.3% | -3.2% | US$5.1b | US$115.08 | PB4.6x | E25.9% | n/a | ||
VKTX | US$38.88 | -8.6% | 81.3% | US$4.4b | US$110.00 | PB4.8x | E21.8% | n/a | ||
RARE | US$43.16 | 1.2% | -5.6% | US$3.9b | US$91.50 | PS7.6x | E56.3% | n/a | ||
CRNX | US$38.98 | -22.8% | 4.8% | US$3.8b | US$75.43 | PS3479.2x | E28.3% | n/a | ||
ACLX | US$67.36 | -10.2% | 21.2% | US$3.7b | US$116.38 | PS23.4x | E22.5% | n/a | ||
BHVN | US$37.48 | -3.6% | -17.3% | US$3.7b | US$65.29 | PB12x | E29.8% | n/a | ||
RNA | US$28.41 | -9.6% | 150.3% | US$3.5b | US$68.27 | PS335x | E34.7% | n/a | ||
IMVT | US$22.75 | -7.6% | -46.3% | US$3.4b | US$50.25 | PB7.4x | E6.2% | n/a | ||
APLS | US$28.59 | -16.8% | -59.3% | US$3.4b | US$45.85 | PS5x | E60.2% | n/a | ||
CRSP | US$38.85 | -8.4% | -39.5% | US$3.4b | US$84.08 | PS16.3x | E47.3% | n/a | ||
SWTX | US$37.01 | -4.8% | -9.6% | US$3.2b | US$67.50 | PS20.3x | E60.4% | n/a | ||
MRUS | US$40.45 | -4.6% | 24.1% | US$3.0b | US$86.07 | PS77.1x | E33.9% | n/a |